Bettina Fabiani

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters

François Lemonnier, Lucile Couronné, Marie Parrens et al. · Blood · 2012 · 492 citations · Full text

Medicine, Molecular Genetics, Oncology +11

Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas

David Vallois, Maria Pamela Dobay, Ryan D. Morin et al. · Blood · 2016 · 318 citations · Full text

Life Sciences, Immunology, Oncology +12

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Christiane Copie‐Bergman, Peggy Cuillière-Dartigues, Maryse Baia et al. · Blood · 2015 · 254 citations · Full text

Life Sciences, Immunology, Oncology +12

Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL)

Jehan Dupuis, K. Boye, Nadine Martin et al. · The American Journal of Surgical Pathology · 2006 · 231 citations

Medicine, Oncology, Pathology +14

Positron Emission Tomography–Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants

Judith Trotman, Marion Fournier, T. Lamy et al. · Journal of Clinical Oncology · 2011 · 219 citations · Full text

Medicine, Oncology, Radiology +16